| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 10/06/2004 | CN1535262A Process for preparation 3-aryl-2-hydroxypropionic acid derivative |
| 10/06/2004 | CN1535168A Controlled release composition and method of producing the same |
| 10/06/2004 | CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl} |
| 10/06/2004 | CN1535144A Pharmaceutical combination comprising either (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic aicd or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl) ethyoxy] phenyl} |
| 10/06/2004 | CN1535142A Transdermal patch for administering fentanyl |
| 10/06/2004 | CN1533808A Composition for treating coronavirus infection and SARS and method |
| 10/05/2004 | US6800660 Bis(thio-hydrazide amide) compounds; anticancer agents |
| 10/05/2004 | US6800053 Without having to disassemble the equipment; novel valve assembly; steam |
| 09/30/2004 | WO2004082702A1 Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 09/30/2004 | WO2004082642A1 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas |
| 09/30/2004 | WO2004082640A2 Human serum albumin conjugates with therapeutic compounds |
| 09/30/2004 | WO2004082639A2 Detecting coronary artery disease with bnp during stress testing |
| 09/30/2004 | WO2004082638A2 Histone deacetylase inhibitors |
| 09/30/2004 | WO2004082635A2 Methods and compositions related to joint inflammation diseases |
| 09/30/2004 | WO2004082634A2 Facially amphiphilic polymers and oligomers and uses thereof |
| 09/30/2004 | WO2004082633A2 A method of treating a systemic disease |
| 09/30/2004 | WO2004082631A2 METHODS FOR PREPARATION AND USE OF 1α,24(S)-DIHYDROXYVITAMIN D2 |
| 09/30/2004 | WO2004082630A2 High potency dopaminergic treatment of neurological impairment associated with brain injury |
| 09/30/2004 | WO2004082629A2 Novel cyclosporins |
| 09/30/2004 | WO2004082628A2 Improved bioavailability and improved delivery of acidic pharmaceutical drugs |
| 09/30/2004 | WO2004082627A2 ENZYME REPLACEMENT THERAPY WITH 17-β-HYDROXYSTEROID DEHYDROGENASE-TYPE 2 |
| 09/30/2004 | WO2004082626A2 Aromatase inhibitor diagnosis and therapy |
| 09/30/2004 | WO2004082625A2 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | WO2004082624A2 Modafinil-based neurorehabilitation of impaired neurological function associated with injury |
| 09/30/2004 | WO2004082622A2 Retinoid replacements and opsin agonists and methods for the use thereof |
| 09/30/2004 | WO2004082621A2 Novel ppar agonists, pharmaceutical compositions and uses thereof |
| 09/30/2004 | WO2004082619A2 Forms of 5-azacytidine |
| 09/30/2004 | WO2004082618A2 Synthesis of 5-azacytidine |
| 09/30/2004 | WO2004082617A2 Biological markers for diagnosing rheumatoid arthritis |
| 09/30/2004 | WO2004082616A2 Tetrahydropyranyl cyclopentyl heterocylic amide modulators of chemokine receptor activity |
| 09/30/2004 | WO2004082615A2 A process for preparing sustained release tablets |
| 09/30/2004 | WO2004082614A2 Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus |
| 09/30/2004 | WO2004082613A2 2,4-diamino-5-[5’-substituted-benzyl] pyrimidines and 2,4-diamino-6-[5’-substituted-benzyl] quinazolines |
| 09/30/2004 | WO2004082612A2 Liposomal formulations and methods of use |
| 09/30/2004 | WO2004082611A2 Poss and eposs containing cosmetics and personal care products |
| 09/30/2004 | WO2004082610A2 Modulation of hyaluronan and cd44 interaction and uses thereof in treating disorders |
| 09/30/2004 | WO2004082609A2 Composition and method for appetite and carving suppression and mood enhancement |
| 09/30/2004 | WO2004082608A2 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | WO2004082606A2 Fused pyrrole compounds |
| 09/30/2004 | WO2004082605A2 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004082604A2 Phosphoric ester demulsifier composition |
| 09/30/2004 | WO2004082603A2 Modified heat-generating cosmetic compositions |
| 09/30/2004 | WO2004082602A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | WO2004082601A2 Method of treating diabetes and diabetes-related disorders |
| 09/30/2004 | WO2004082600A2 Method and system for administering a drug |
| 09/30/2004 | WO2004082599A2 Combination of an aldosterone receptor antagonist and an anti-diabetic agent |
| 09/30/2004 | WO2004082598A2 Relaxin3-gpcr135 complexes and their production and use |
| 09/30/2004 | WO2004082597A2 Homeopathic formulations useful for treating pain and/or inflammmation |
| 09/30/2004 | WO2004082594A2 Alginate sponge and preparation method thereof |
| 09/30/2004 | WO2004082592A2 Metal amino acid chelates having nutritionally relevant anion radical (s) |
| 09/30/2004 | WO2004082591A2 Pharmaceutical composition for treatment of diabetes mellitus |
| 09/30/2004 | WO2004082590A2 A low dose corticosteroid composition |
| 09/30/2004 | WO2004082589A2 Nasally administrable, bioavailable pharmaceutical composition of loratadine |
| 09/30/2004 | WO2004082588A2 Dispersible formulation of an anti-inflammatory agent |
| 09/30/2004 | WO2004082587A2 Stable lamotrigine pharmaceutical compositions and processes for their preparation |
| 09/30/2004 | WO2004082580A2 Photostabilized topical formulations of ketoprofen containing two uv filters |
| 09/30/2004 | WO2004082577A2 8-SUBSTITUTED-6, 7, 8, 9-TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/30/2004 | WO2004082564A2 Coated enzyme granules |
| 09/30/2004 | WO2004073603A3 Dna vaccine that expresses mutant adp-ribosyltransferase toxins which display reduced, or are devoid of, adp-ribosyltransferase activity |
| 09/30/2004 | WO2004064785A9 Cancer therapy sensitizer |
| 09/30/2004 | WO2004060315A3 Stable topical drug delivery compositions |
| 09/30/2004 | WO2004060295A3 Methods of inducing and maintaining immune tolerance |
| 09/30/2004 | WO2004052307A3 Encapsulated material released to generate perceivable sensorial indicia |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2004043401A3 Method of preparing anti-angiogenic drug from cartillage and chondrocytes and methods of use |
| 09/30/2004 | WO2004043349A3 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 09/30/2004 | WO2004043346A3 Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
| 09/30/2004 | WO2004041180A3 Compositions for lowering blood pressure |
| 09/30/2004 | WO2004037180A3 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 09/30/2004 | WO2004037164A3 Crosslinked compounds and methods of making and using thereof |
| 09/30/2004 | WO2004034992A3 Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | US20040194158 Model for neurodegenerative disorders |
| 09/30/2004 | US20040194157 Animal with surgically modified gastrointestinal tract and method for study of weight reduction |
| 09/30/2004 | US20040193019 Methods for predicting an individual's clinical treatment outcome from sampling a group of patient's biological profiles |
| 09/30/2004 | US20040192784 Synergistic mixture; containing hydroxy-3-methylglutaryl/3-/ coenzyme a inhibitor |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192716 Mixture with 2-amino-1,3-propanediol and excipients; synergistic mixture; concurrent administering |
| 09/30/2004 | US20040192715 Methods of administering opioid antagonists and compositions thereof |
| 09/30/2004 | US20040192706 Oral administering; sustained release of ocinaplonin |
| 09/30/2004 | US20040192654 use of nucleoside analogues as an effective treatment for acute or chronic myelogenous leukemia; (-)- beta -L-Dioxolane-Cytidine ( beta -L-oddC); (-)- beta -Dioxolane-5-fluoro-Cytidine (5-FddC) |
| 09/30/2004 | US20040192653 P38 inhibitors and methods of use thereof |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040191328 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
| 09/30/2004 | US20040191284 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | US20040191246 Process for in vivo treatment of specific biological targets in bodily fluid |
| 09/30/2004 | US20040191228 Methods of kidney transplantation utilizing developing nephric tissue |
| 09/30/2004 | CA2527916A1 Biological markers for diagnosing rheumatoid arthritis |
| 09/30/2004 | CA2519475A1 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 09/30/2004 | CA2519300A1 Self-emulsifying compositions, methods of use and preparation |
| 09/30/2004 | CA2519297A1 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 09/30/2004 | CA2519182A1 Methods and compositions related to joint inflammation diseases |
| 09/30/2004 | CA2519131A1 Ligands for tgf-beta binding proteins and uses thereof |
| 09/30/2004 | CA2519126A1 Improved bioavailability and improved delivery of acidic pharmaceutical drugs |
| 09/30/2004 | CA2519125A1 Dispersible formulation of an anti-inflammatory agent |
| 09/30/2004 | CA2519109A1 Methods for treating cancer using perna canaliculus component(s) and extracts of perna canaliculus |
| 09/30/2004 | CA2519023A1 Facially amphiphilic polymers and oligomers and uses thereof |
| 09/30/2004 | CA2518965A1 Homeopathic formulations useful for treating pain and/or inflammmation |
| 09/30/2004 | CA2518833A1 Modified heat-generating cosmetic compositions |
| 09/30/2004 | CA2518830A1 Carboxamide spirohydantoin cgrp receptor antagonists |